You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金斯瑞生物科技(01548.HK):傳奇生物獲高瓴完成認購48.4992萬股、對價約1270萬美元

格隆匯5月7日丨金斯瑞生物科技(01548.HK)公佈,2023年5月6日,董事會從傳奇生物獲悉,傳奇生物於2023年4月26日(紐約時間)(香港2023年4月27日交易時段前)與投資者LGN Holdings Limited訂立認購協議,據此,傳奇生物同意於交割時通過定向增發發行及出售而投資者同意購買484,992股傳奇生物股份,對價約1270萬美元(相當於約9940萬港元),交割於2023年5月2日(紐約時間)(香港2023年5月3日交易時段前)發生。

緊接完成前,傳奇生物由公司間接非全資擁有約51.44%。緊隨定向增發完成後,公司於傳奇生物的股權被攤薄及下降至51.36%(未計及日後配發、發行、行使及歸屬僱員股份擁有權計劃股份,並假設傳奇認股權證未行使)。因此,根據上市規則第14.29條,定向增發構成視作出售公司於傳奇生物的股權。

傳奇生物擬將定向增發所得款項淨額用作一般營運資金、業務擴張及其他公司用途。

公吿顯示,LGN Holdings Limited為根據開曼羣島法律註冊成立的獲豁免有限公司,其唯一投資管理人為Hillhouse Investment Management, Ltd.(“高瓴投資”)。

高瓴投資成立於2005年,專注於發現價值,創造價值,是亞洲領先、業績優秀的私募股權投資機構。高瓴投資專注於長期投資,致力於與最優秀的企業家合作,通過科技創新,共同創造長期價值。基於全球運營專家及管理人才網路,高瓴投資堅持獨立的基礎行業研究,投資覆蓋生命健康、企業服務、先進製造和大消費等領域。高瓴投資受託管理的資金主要來自於全球性機構投資人。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account